Tag: Aldeyra Therapeutics Inc

Finance

Biotech Unusual Volume: Aldeyra Therapeutics (NASDAQ:ALDX), Alcobra (NASDAQ:ADHD), Receptos (NASDAQ:RCPT), Celsus Therapeutics (NASDAQ:CLTX)

Aldeyra Therapeutics Inc (NASDAQ:ALDX) rallied to a new all-time high Thursday after Aegis Capital began coverage of the biotech company working to develop treatments for rare skin and eye diseases with a Buy rating. Aldeyra Therapeutics Inc (NASDAQ:ALDX) stock performance was 12.26% in last session and finished the day at $7.51. Traded volume was 134,905.00million shares in the last session and the average volume of … Continue reading Biotech Unusual Volume: Aldeyra Therapeutics (NASDAQ:ALDX), Alcobra (NASDAQ:ADHD), Receptos (NASDAQ:RCPT), Celsus Therapeutics (NASDAQ:CLTX)

John Meady
Finance

Healthcare Decliners: Aldeyra Therapeutics (NASDAQ:ALDX), Ignyta (NASDAQ:RXDX), Vital Therapies (NASDAQ:VTL), Actinium (NYSEMKT:ATNM), TrovaGene (NASDAQ:TROV)

Aldeyra Therapeutics Inc (NASDAQ:ALDX) quiet period is set to expire on Wednesday, June 11th. Aldeyra Therapeutics had issued 1,500,000 shares in its IPO on May 2nd, AR Network reports. The total size of the offering was $12,000,000 based on an initial share price of $8.00. Aldeyra Therapeutics Inc (NASDAQ:ALDX) stock performance was -7.08% in last session and finished the day at $6.69. Traded volume was … Continue reading Healthcare Decliners: Aldeyra Therapeutics (NASDAQ:ALDX), Ignyta (NASDAQ:RXDX), Vital Therapies (NASDAQ:VTL), Actinium (NYSEMKT:ATNM), TrovaGene (NASDAQ:TROV)

Jayne Crisman
Finance

Stock Alert: Qihoo 360 Technology (NYSE:QIHU), Aldeyra Therapeutics Inc (NASDAQ:ALDX), Broadway Financial (NASDAQ:BYFC), Astea International Inc. (NASDAQ:ATEA), Euro Tech Holdings (NASDAQ:CLWT)

Qihoo 360 Technology Co Ltd (NYSE:QIHU) has made some solid progress in the Chinese internet industry. And now it is giving tough competition to its peers such as Baidu. In fact, it has been able to take some of its market share and is now competing with Tencent in the gaming market as well. Qihoo 360 Technology Co Ltd (NYSE:QIHU) stock performance was 1.24% in … Continue reading Stock Alert: Qihoo 360 Technology (NYSE:QIHU), Aldeyra Therapeutics Inc (NASDAQ:ALDX), Broadway Financial (NASDAQ:BYFC), Astea International Inc. (NASDAQ:ATEA), Euro Tech Holdings (NASDAQ:CLWT)

Colin Pettis
FB Nasdaq FB Facebook
Finance

Biotech decliners: Aldeyra Therapeutics Inc (NASDAQ:ALDX), Uniqure NV (NASDAQ:QURE), Regulus Therapeutics Inc (NASDAQ:RGLS), Genetic Technologies Limited (ADR) (NASDAQ:GENE)

Aldeyra Therapeutics Inc (NASDAQ:ALDX) Director C. Boyd Clarke purchased 12,500 shares of the stock in a transaction dated Wednesday, May 7th. The stock was purchased at an average price of $8.00 per share, with a total value of $100,000.00. Following the acquisition, the director now directly owns 12,500 shares in the company, valued at approximately $100,000. Aldeyra Therapeutics Inc (NASDAQ:ALDX) stock performance was -8.31% in … Continue reading Biotech decliners: Aldeyra Therapeutics Inc (NASDAQ:ALDX), Uniqure NV (NASDAQ:QURE), Regulus Therapeutics Inc (NASDAQ:RGLS), Genetic Technologies Limited (ADR) (NASDAQ:GENE)

Colin Pettis